Biocryst Pharmaceuticals reported $511.71M in Current Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
DBV Technologies DBVT:US 90.44M 23.95M
Alnylam Pharmaceuticals ALNY:US $ 2589.68M 218.9M
Biocryst Pharmaceuticals BCRX:US $ 511.71M 54.42M
Chemocentryx CCXI:US $ 351.63M 82.46M
Chugai Pharma 4519:JP Y 1091648M 27987M
Daiichi Sankyo 4568:JP Y 1345271M 34628M
Enanta Pharmaceuticals ENTA:US $ 341.87M 14.91M
Gilead Sciences GILD:US $ 12629M 2143M
GlaxoSmithKline GSK:LN 28.99B 10.31B
Glaxosmithkline GSK:US $ 28988M 10314M
Intra Cellular Therapies ITCI:US $ 848.34M 381.06M
IONIS PHARMACEUT IONS:US $ 2253.12M 91.92M
Karyopharm Therapeutics KPTI:US $ 276.53M 927K
Mirati Therapeutics MRTX:US $ 1343.12M 164.87M
Neurocrine Biosciences NBIX:US $ 1018.2M 45.4M
Novavax NVAX:US $ 2347.41M 192.29M
Ptc Therapeutics PTCT:US $ 774.01M 180.36M
Regeneron Pharmaceuticals REGN:US $ 14306M 291.1M
Sarepta Therapeutics SRPT:US $ 2530.95M 73.15M
Ultragenyx Pharmaceutical RARE:US $ 707.52M 149.08M
Vertex Pharmaceuticals VRTX:US $ 10361.3M 800.7M
YTE INCY:US $ 3288.09M 169.42M